Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
DOCS' revenues top estimates as AI tool adoption and large customer growth fuel engagement despite weaker earnings and margin pressure.
Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
Doximity Q4 Earnings Call Highlights
Doximity NYSE: DOCS reported fiscal fourth-quarter revenue above the high end of its guidance and said it is entering what management called an “AI investment year,” with higher spending planned for artificial intelligence products even as near-term growth in the digital pharma advertising market remains soft.
Doximity (DOCS) Lags Q4 Earnings Estimates
Doximity (DOCS) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.38 per share a year ago.
Insights Into Doximity (DOCS) Q4: Wall Street Projections for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Doximity (DOCS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.
Why the Market Dipped But Doximity (DOCS) Gained Today
The latest trading day saw Doximity (DOCS) settling at $26.03, representing a +1.32% change from its previous close.
3 Medical Info Systems Stocks Riding the GenAI Wave in a Tough Market
Doximity, Veeva and Omnicell ride surging GenAI adoption in healthcare, tapping digital demand despite market pressure and rising cybersecurity risks.
Doximity: Buy It As Mr. Market Is Selling It Cheap Under A Panic Attack
Doximity has seen a two-thirds stock price decline, which I attribute mainly to market overreaction and short-term uncertainty, not deteriorating fundamentals. DOCS maintains a robust business model with 90% gross margins, ~30% net margins, strong cash generation, and a dominant network among U.S. healthcare professionals. Recent growth deceleration and vague pharma client budget concerns have pressured the stock, but DOCS remains asset-light with minimal downside risk and ample liquidity.
Doximity (DOCS) Outperforms Broader Market: What You Need to Know
In the latest trading session, Doximity (DOCS) closed at $24.66, marking a +2.71% move from the previous day.
Wall Street Analysts Think Doximity (DOCS) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know
Doximity (DOCS) reached $24.39 at the closing of the latest trading day, reflecting a -1.3% change compared to its last close.
Doximity (DOCS) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Doximity (DOCS) stood at $22.25, denoting a -1.81% move from the preceding trading day.
